Abstract 6015: Unveiling RYK: A breakthrough tumor-associated antigen in lymphoma treatmentMatilde Micillo, Silvia Deaglio, Beatrice Pirajno et al.|Cancer Research|2025Cited by 0
Targeting a novel surface antigen, ryk, with the antibody-drug conjugate, slv-404, is effective in richter transformation patient-derived xenograftsMatilde Micillo, Silvia Deaglio, Giulia Omezzolli et al.|Blood|2025Cited by 0